Anti-Factor Xi Monoclonal Antibodies And Methods Of Use Thereof

Patent No. EP3002298 (titled "Anti-Factor Xi Monoclonal Antibodies And Methods Of Use Thereof") was filed by Oregon Health & Science University on Nov 21, 2008. The application was issued on Aug 28, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERCK SHARP & DOHMEApr 8, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3002298

OREGON HEALTH & SCIENCE UNIVERSITY
Application Number
EP15189714A
Filing Date
Nov 21, 2008
Status
Revoked
Mar 25, 2022
Publication Date
Aug 28, 2019